Metraipolis › archive › dc_892270444ebb
Impact of cilostazol on clinical outcomes in lower extremity arterial disease patients after angioplasty: A real-world analysis — Europe PMC PMID:40839648
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40839648
- DOI
- 10.1371/journal.pone.0330434
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T11:09:08.940Z
- SHA-256 of the archived text
4f4893f1fbc9e35d2e76b1747c81edd58c24bd7e1d160475468e80a7520a1b88- Stable URL of this page
https://metraipolis.com/documento/dc_892270444ebb
How to cite
Impact of cilostazol on clinical outcomes in lower extremity arterial disease patients after angioplasty: A real-world analysis — Europe PMC PMID:40839648 — Europe PMC (en), https://europepmc.org/article/MED/40839648 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_892270444ebb (Metraipolis archive dc_892270444ebb, sha256 4f4893f1fbc9e35d2e76b1747c81edd58c24bd7e1d160475468e80a7520a1b88)
BibTeX
@misc{dc892270444ebb,
title = {Impact of cilostazol on clinical outcomes in lower extremity arterial disease patients after angioplasty: A real-world analysis — Europe PMC PMID:40839648},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40839648},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_892270444ebb; sha256 4f4893f1fbc9e35d2e76b1747c81edd58c24bd7e1d160475468e80a7520a1b88},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40839648. Agents can read the archived copy with the MCP tool read_document.